COVID-19 Pandemic

January 24, 2022: An MSF study shows why the COVAX donation scheme to distribute vaccines to low-income countries has fallen short of its promises for global vaccine equity. As of November 2021, more than 73% of people in high-income countries (HICs) had received at least one dose of a COVID-19 vaccine, compared with less than 6% of people in low-income countries. COVAX only raised half of its target of $2billion by the end of 2021, its main sponsors have not supported proposals to share vaccine knowledge through waiving monopolies on vaccines to increase global production .

18 January, 2022: Following a World Health Organization (WHO) recommendation of the drug baricitinib as a therapeutic medicine for COVID19, public health advocates at Médecins Sans Frontières/Doctors Without Borders (MSF) have called on the World Trade Organisation to lift intellectual property monopolies on COVID19 treatments and vaccines.

January 13, 2022: As Big Pharma continues to block efforts to lift intellectual property monopolies on COVID19 vaccines, a team of scientists in Texas have announced in the Scientific American plans to deliver a ‘COVID vaccine for all’.

12 January 2022:  A group of institutional investors representing $3.5 trillion in assets under management have called on pharmaceutical companies to link their executives' pay to global vaccine equity.

January 11, 2022: The World Trade Organisation General Council met virtually on January 10. This was a response to India’s recent proposal to hold an urgent virtual Ministerial Conference on the WTO’s response to the COVID-19 pandemic, including a proposed temporary waiver of WTO intellectual property rules on vaccine monopolies, which would enable production of affordable vaccines in low-income countries.

December 21, 2021: After the WTO Ministerial Conference (MC12) was postponed in November, discussions on the proposal to lift vaccine patent monopolies (known as the ‘TRIPS waiver’) have intensified, as WTO Ministers from South Africa, India, the United States and the European Union met online to discuss a way forward and find common ground.

December 16, 2021: Nobel Laureate in economics, Joseph Stiglitz, has called on the new German Chancellor Olaf Scholz to support a proposal at the World Trade Organisation (WTO) to lift intellectual property patents on COVID19 vaccines.

December 16, 2021: As World Trade Organisation (WTO) delegates meet today to discuss a proposal to temporarily lift vaccine intellectual property patents, vaccine equity advocates are calling for immediate action amid a ‘tsunami’ of Omicron cases.

December 12, 2021: A coalition of thirty-three civil society organisations has written to New Zealand Prime Minister Jacinda Ardern this week, calling for NZ to use its bilateral trade negotiations with the United Kingdom and European Union to push for their support of a proposal to temporarily lift patent monopolies on vaccines at the World Trade Organisation (WTO).

December 14, 2021: Prime Minister Scott Morrison has today announced that Australia will produce millions of mRNA vaccines from 2024 through an ‘in-principle’ deal struck between Moderna, the Federal Government, and the Victorian Government to build a local manufacturing facility in the state.